All Stories

  1. The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis

    Article • Expert Review of Anti-infective Therapy, June 2025, Taylor & Francis

    Professor Guillermo Quindós

  2. In Vitro Assessment of Fluconazole and Cyclosporine A Antifungal Activities: A Promising Drug Combination Against Different Candida Species

    Article • Journal of Fungi, February 2025, MDPI AG

    Professor Guillermo Quindós

  3. Characterization of Yeast Isolated from the Gut Microbiota of Tunisian Children with Autism Spectrum Disorder

    Article • Journal of Fungi, October 2024, MDPI AG

    Professor Guillermo Quindós

  4. Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

    Article • Microbiology Spectrum, November 2023, ASM Journals

    Professor Guillermo Quindós

  5. In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

    Article • Journal of Fungi, June 2023, MDPI AG

    Professor Guillermo Quindós

  6. Presence and implication of Candida spp. in patients with peri‐implantitis enrolled in a supportive peri‐implant therapy program of the Basque Country (Spain). A case–control study

    Article • Clinical Implant Dentistry and Related Research, May 2023, Wiley

    Professor Guillermo Quindós

  7. PK / PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris

    Article • CPT Pharmacometrics & Systems Pharmacology, March 2023, Wiley

    Professor Guillermo Quindós

  8. Assessing pH‐dependent activities of virulence factors secreted by Candida albicans

    Article • MicrobiologyOpen, January 2023, Wiley

    Professor Guillermo Quindós

  9. Antimicrobial Peptides with Anti-Candida Activity

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Professor Guillermo Quindós

  10. Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

    Article • Journal of Fungi, July 2022, MDPI AG

    Professor Guillermo Quindós

  11. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Article • Frontiers in Cellular and Infection Microbiology, May 2022, Frontiers

    Professor Guillermo Quindós

  12. In vitro and in vivo anti-Candida activity of citral in combination with fluconazole

    Article • Journal of Oral Microbiology, March 2022, Taylor & Francis

    Professor Guillermo Quindós

  13. Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins

    Article • Journal of Fungi, November 2021, MDPI AG

    Professor Guillermo Quindós

  14. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms

    Article • Biomedicine & Pharmacotherapy, November 2021, Elsevier

    Professor Guillermo Quindós

  15. In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida auris

    Article • Pharmaceutics, October 2021, MDPI AG

    Professor Guillermo Quindós

  16. In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris

    Article • Pharmaceutics, August 2021, MDPI AG

    Professor Guillermo Quindós

  17. A systematic review on the implication of Candida in peri-implantitis

    Article • International Journal of Implant Dentistry, June 2021, Springer Science + Business Media

    Professor Guillermo Quindós

  18. Erratum for Miranda-Cadena et al., “Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti- Candida Activities”

    Article • Antimicrobial Agents and Chemotherapy, May 2021, ASM Journals

    Professor Guillermo Quindós

  19. Anfotericina B liposomal: treinta años de una herramienta muy eficaz para el tratamiento de las micosis invasoras

    Article • Revista Iberoamericana de Micología, April 2021, Elsevier

    Professor Guillermo Quindós

  20. In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris

    Article • Antibiotics, March 2021, MDPI AG

    Professor Guillermo Quindós

  21. Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti- Candida Activities

    Article • Antimicrobial Agents and Chemotherapy, March 2021, ASM Journals

    Professor Guillermo Quindós

  22. Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates

    Article • Journal of Fungi, January 2021, MDPI AG

    Professor Guillermo Quindós

  23. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models

    Article • Virulence, January 2021, Taylor & Francis

    Professor Guillermo Quindós

  24. Candida duobushaemulonii: An Old But Unreported Pathogen

    Article • Journal of Fungi, December 2020, MDPI AG

    Professor Guillermo Quindós

  25. Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis , and Candida bracarensis Virulence and Antifungal Efficacy

    Article • Antimicrobial Agents and Chemotherapy, September 2020, ASM Journals

    Professor Guillermo Quindós

  26. Fungal co-infection in COVID-19 patients: Should we be concerned?

    Article • Revista Iberoamericana de Micología, April 2020, Elsevier

    Professor Guillermo Quindós

  27. Synthesis, Physical, Mechanical and Antibacterial Properties of Nanocomposites Based on Poly(vinyl alcohol)/Graphene Oxide–Silver Nanoparticles

    Article • Polymers, March 2020, MDPI AG

    Professor Guillermo Quindós

  28. Utility of two PCR‐RFLP‐based techniques for identification of Candida parapsilosis complex blood isolates

    Article • Mycoses, March 2020, Wiley

    Professor Guillermo Quindós

  29. Graphene Oxide–Silver Nanoparticle Nanohybrids: Synthesis, Characterization, and Antimicrobial Properties

    Article • Nanomaterials, February 2020, MDPI AG

    Professor Guillermo Quindós

  30. Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses

    Article • Medicina Oral Patología Oral y Cirugia Bucal, January 2020, Medicina Oral, S.L.

    Professor Guillermo Quindós

  31. Disinfectant Activity of A Portable Ultraviolet C Equipment

    Article • International Journal of Environmental Research and Public Health, November 2019, MDPI AG

    Professor Guillermo Quindós

  32. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review

    Article • Journal of Periodontal Research, September 2019, Wiley

    Professor Guillermo Quindós

  33. One-step eco-friendly synthesized silver-graphene oxide/poly(vinyl alcohol) antibacterial nanocomposites

    Article • Carbon, September 2019, Elsevier

    Professor Guillermo Quindós

  34. Effect of biomaterials hydrophobicity and roughness on biofilm development

    Article • Journal of Materials Science Materials in Medicine, June 2019, Springer Science + Business Media

    Professor Guillermo Quindós

  35. Corrigendum: Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida

    Article • Frontiers in Microbiology, June 2019, Frontiers

    Professor Guillermo Quindós

  36. Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity

    Article • Revista Iberoamericana de Micología, January 2019, Elsevier

    Professor Guillermo Quindós

  37. Therapeutic tools for oral candidiasis: Current and new antifungal drugs

    Article • Medicina Oral Patología Oral y Cirugia Bucal, January 2019, Medicina Oral, S.L.

    Professor Guillermo Quindós

  38. Antifungal Activity of the Human Uterine Cervical Stem Cells Conditioned Medium (hUCESC-CM) Against Candida albicans and Other Medically Relevant Species of Candida

    Article • Frontiers in Microbiology, November 2018, Frontiers

    Professor Guillermo Quindós

  39. Epidemiología de las micosis invasoras: un paisaje en continuo cambio

    Article • Revista Iberoamericana de Micología, November 2018, Elsevier

    Professor Guillermo Quindós

  40. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis

    Article • Archives of Oral Biology, November 2018, Elsevier

    Professor Guillermo Quindós

  41. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods

    Article • Antimicrobial Agents and Chemotherapy, October 2018, ASM Journals

    Professor Guillermo Quindós, Dr Eric Dannaoui

  42. Design and validation of a multiplex PCR protocol for microsatellite typing of Candida parapsilosis sensu stricto isolates

    Article • BMC Genomics, September 2018, Springer Science + Business Media

    Professor Guillermo Quindós

  43. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris

    Article • International Microbiology, July 2018, Springer Science + Business Media

    Professor Guillermo Quindós

  44. Oral Candida colonization in patients with chronic periodontitis. Is there any relationship?

    Article • Revista Iberoamericana de Micología, July 2018, Elsevier

    Professor Guillermo Quindós

  45. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

    Article • Medical Mycology, March 2018, Oxford University Press (OUP)

    Professor Guillermo Quindós

  46. Declaración a favor de la creación de la Asociación Iberoamericana de Micología Médica

    Article • Revista Iberoamericana de Micología, October 2017, Elsevier

    Professor Guillermo Quindós

  47. Editorial: EHUDW01, First EHU-DELFIN Program Workshop, Bilbao, Jul, 201

    Article • August 2017, MDPI AG

    Professor Guillermo Quindós

  48. Comparative Study of Invasive Candidiasis in Mexico and Spain

    Article • August 2017, MDPI AG

    Professor Guillermo Quindós

  49. Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts

    Article • Microbial Pathogenesis, August 2017, Elsevier

    Professor Guillermo Quindós, Assos. Prof. Dr. Ozgur CEYLAN

  50. EPICO 4.0. ‘Total quality’ in the management of invasive candidiasis in critically ill patients by analysing the integrated process

    Article • Revista Iberoamericana de Micología, July 2017, Elsevier

    Professor Guillermo Quindós

  51. Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence

    Article • Mycopathologia, May 2017, Springer Science + Business Media

    Professor Guillermo Quindós

  52. Vancomycin heteroresistant community associated methicillin-resistant Staphylococcus aureus ST72-SCCmecIVa strain colonizing the nostrils of a five-year-old Spanish girl

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2017, Elsevier

    Professor Guillermo Quindós

  53. Vancomycin heteroresistant community associated methicillin-resistant Staphylococcus aureus ST72-SCCmecIVa strain colonizing the nostrils of a five-year-old Spanish girl

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), March 2017, Elsevier

    Professor Guillermo Quindós

  54. In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis

    Article • Mycopathologia, January 2017, Springer Science + Business Media

    Professor Guillermo Quindós

  55. Detection and characterization of surface microbial contamination in emergency ambulances

    Article • American Journal of Infection Control, January 2017, Elsevier

    Professor Guillermo Quindós

  56. Erratum to: “EPICO 3.0. Management of non-neutropenic patients in medical wards” [Rev Iberoam Micol. 33 (4) (2016) 216–223]

    Article • Revista Iberoamericana de Micología, January 2017, Elsevier

    Professor Guillermo Quindós

  57. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients

    Article • Medicina Intensiva, January 2017, Elsevier

    Professor Guillermo Quindós

  58. Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative †

    Article • Journal of Microbiology and Biology Education, December 2016, ASM Journals

    Professor Guillermo Quindós, Manuel Sanchez

  59. Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades

    Article • Diagnostic Microbiology and Infectious Disease, October 2016, Elsevier

    Professor Guillermo Quindós

  60. EPICO 3.0. Management of non-neutropenic patients in medical wards

    Article • Revista Iberoamericana de Micología, October 2016, Elsevier

    Professor Guillermo Quindós

  61. Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?

    Article • International Journal of Nanomedicine, August 2016, Dove Medical Press

    Professor Guillermo Quindós

  62. Enfermedad fúngica invasiva por Candida y otros hongos levaduriformes

    Article • Revista Iberoamericana de Micología, July 2016, Elsevier

    Professor Guillermo Quindós

  63. Aspectos actuales de las enfermedades invasoras causadas por Candida y otros hongos levaduriformes

    Article • Revista Iberoamericana de Micología, July 2016, Elsevier

    Professor Guillermo Quindós

  64. In vitro pharmacodynamic modelling of anidulafungin against Candida spp.

    Article • International Journal of Antimicrobial Agents, March 2016, Elsevier

    Professor Guillermo Quindós

  65. Caries andCandidacolonisation in adult patients in Basque Country (Spain)

    Article • Mycoses, January 2016, Wiley

    Professor Guillermo Quindós

  66. Risk Groups for Acquiring Fungal Infections

    Article • January 2016, Elsevier

    Professor Guillermo Quindós

  67. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  68. Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis

    Article • PLOS One, July 2015, PLOS

    Professor Guillermo Quindós

  69. Comparison of the in vitro activity of echinocandins against Candida albicans , Candida dubliniensis , and Candida africana by time–kill curves

    Article • Diagnostic Microbiology and Infectious Disease, May 2015, Elsevier

    Professor Guillermo Quindós

  70. In VitroFungicidal Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis Evaluated by Time-Kill Studies

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Professor Guillermo Quindós

  71. Enfermedad fúngica invasiva por hongos filamentosos

    Article • Revista Iberoamericana de Micología, October 2014, Elsevier

    Professor Guillermo Quindós

  72. Aspectos actuales de las enfermedades invasivas por hongos filamentosos

    Article • Revista Iberoamericana de Micología, October 2014, Elsevier

    Professor Guillermo Quindós

  73. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations

    Article • Revista Iberoamericana de Micología, July 2014, Elsevier

    Professor Guillermo Quindós

  74. Candidaantigens and immune responses: implications for a vaccine

    Article • Expert Review of Vaccines, June 2014, Taylor & Francis

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  75. Epidemiology of candidaemia and invasive candidiasis. A changing face

    Article • Revista Iberoamericana de Micología, January 2014, Elsevier

    Professor Guillermo Quindós

  76. State of the Art in the Laboratory Methods for the Diagnosis of Invasive Fungal Diseases

    Article • January 2014, Elsevier

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  77. List of Contributors

    Article • January 2014, Elsevier

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  78. Presencia de Candida en la estomatitis aftosa recidivante

    Article • Revista Iberoamericana de Micología, October 2013, Elsevier

    Professor Guillermo Quindós

  79. Épico project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients

    Article • Revista Española de Anestesiología y Reanimación, August 2013, Elsevier

    Professor Guillermo Quindós

  80. Proyecto Épico: formulación de unas recomendaciones educativas con metodología DELPHI para pacientes adultos críticos no neutropénicos y con candidiasis invasiva

    Article • Revista Iberoamericana de Micología, July 2013, Elsevier

    Professor Guillermo Quindós

  81. Épico project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients

    Article • Revista Iberoamericana de Micología, July 2013, Elsevier

    Professor Guillermo Quindós

  82. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis

    Article • Expert Review of Anti-infective Therapy, April 2013, Taylor & Francis

    Professor Guillermo Quindós

  83. Enfermedad fúngica invasora: ¿Diagnóstico micológico convencional o molecular?

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2012, Elsevier

    Professor Guillermo Quindós

  84. Accurate Identification of Candida parapsilosis (Sensu Lato) by Use of Mitochondrial DNA and Real-Time PCR

    Article • Journal of Clinical Microbiology, April 2012, ASM Journals

    Professor Guillermo Quindós

  85. Validation of the PCR–dHPLC method for rapid identification of Candida glabrata phylogenetically related species in different biological matrices

    Article • Journal of Chromatography B, April 2012, Elsevier

    Professor Guillermo Quindós

  86. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Article • Journal of Antimicrobial Chemotherapy, February 2012, Oxford University Press (OUP)

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  87. Periodontopathogen and Epstein-Barr Virus Contamination Affects Transplanted Bone Volume in Sinus Augmentation

    Article • The Journal of Periodontology, February 2012, Wiley

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  88. In vitro activities of natural products against oral Candida isolates from denture wearers

    Article • BMC Complementary and Alternative Medicine, November 2011, Springer Science + Business Media

    Professor Guillermo Quindós

  89. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2011, Elsevier

    Professor Guillermo Quindós

  90. Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia

    Article • Antimicrobial Agents and Chemotherapy, September 2011, ASM Journals

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  91. Anidulafungin in Treatment of Experimental Invasive Infection by Candida parapsilosis:In VitroActivity, (1→3)-β-d-Glucan and Mannan Serum Levels, Histopathological Findings, andIn VivoEfficacy

    Article • Antimicrobial Agents and Chemotherapy, August 2011, ASM Journals

    Professor Guillermo Quindós

  92. In Vitro Activities of New Triazole Antifungal Agents, Posaconazole and Voriconazole, Against Oral Candida Isolates from Patients Suffering from Denture Stomatitis

    Article • Mycopathologia, August 2011, Springer Science + Business Media

    Professor Guillermo Quindós

  93. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

    Article • Journal of Antimicrobial Chemotherapy, July 2011, Oxford University Press (OUP)

    Professor Guillermo Quindós

  94. Enfermedades fúngicas invasoras en receptores de trasplante de órgano sólido

    Article • Revista Iberoamericana de Micología, July 2011, Elsevier

    Professor Guillermo Quindós

  95. Candidiasis, aspergilosis y otras micosis invasoras en receptores de trasplantes de órgano sólido

    Article • Revista Iberoamericana de Micología, July 2011, Elsevier

    Professor Guillermo Quindós

  96. Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2011, Elsevier

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  97. Fungicidal Monoclonal Antibody C7 Interferes with Iron Acquisition in Candida albicans

    Article • Antimicrobial Agents and Chemotherapy, April 2011, ASM Journals

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  98. Saccharomyces cerevisiae Vaginitis: Microbiology and In Vitro Antifungal Susceptibility

    Article • Mycopathologia, March 2011, Springer Science + Business Media

    Professor Guillermo Quindós

  99. Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients

    Article • BMC Infectious Diseases, March 2011, Springer Science + Business Media

    Professor Guillermo Quindós

  100. Evidencias científicas que respaldan el uso de micafungina en el tratamiento de la candidiasis invasora

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2011, Elsevier

    Professor Guillermo Quindós

  101. Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method

    Article • International Journal of Antimicrobial Agents, March 2011, Elsevier

    Professor Guillermo Quindós

  102. In memoriam a José Pontón

    Article • Gaceta Médica de Bilbao, January 2011, Elsevier

    Professor Guillermo Quindós

  103. Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2011, Elsevier

    Professor Guillermo Quindós, Dr Ferran Sanchez-Reus

  104. Evaluation of the VITEK 2 system to test the susceptibility ofCandidaspp.,Trichosporon asahiiandCryptococcus neoformansto amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method

    Article • Medical Mycology, August 2010, Oxford University Press (OUP)

    Professor Guillermo Quindós

  105. In vitroactivity of voriconazole against Mexican oral yeast isolates

    Article • Mycoses, May 2010, Wiley

    Professor Guillermo Quindós

  106. Candidemias y candidiasis invasivas nosocomiales

    Article • Medicina Clínica, January 2010, Elsevier

    Professor Guillermo Quindós

  107. Phospholipase and proteinase activities of Candida isolates from denture wearers

    Article • Mycoses, December 2009, Wiley

    Professor Guillermo Quindós

  108. Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin Therapy

    Article • Antimicrobial Agents and Chemotherapy, September 2009, ASM Journals

    Professor Guillermo Quindós

  109. Kinetic Patterns of Candida albicans Germ Tube Antibody in Critically Ill Patients: Influence on Mortality

    Article • Clinical and Vaccine Immunology, August 2009, ASM Journals

    Professor Guillermo Quindós

  110. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity

    Article • Journal of Medical Microbiology, July 2009, Society for General Microbiology

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  111. La Revista Iberoamericana de Micología se debe adaptar a los tiempos actuales

    Article • Revista Iberoamericana de Micología, June 2009, Elsevier

    Professor Guillermo Quindós

  112. Confundiendo al confuso: reflexiones sobre el factor de impacto, el índice h(irsch), el valor Q y otros cofactores que influyen en la felicidad del investigador

    Article • Revista Iberoamericana de Micología, June 2009, Elsevier

    Professor Guillermo Quindós

  113. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients

    Article • Clinical Microbiology and Infection, June 2009, Elsevier

    Professor Guillermo Quindós

  114. Evaluation of two commercialized systems for the rapid identification of medically important yeasts

    Article • Mycoses, April 2009, Wiley

    Professor Guillermo Quindós

  115. Transient fungaemia due to Candida, pelliculosa in a patient with AIDS

    Article • Mycoses, April 2009, Wiley

    Professor Guillermo Quindós

  116. Evaluation of the Albicans IDR plate method for the rapid identification of Candida albicans

    Article • Mycoses, April 2009, Wiley

    Professor Guillermo Quindós

  117. Actividad antifúngica in vitro de la micafungina

    Article • Revista Iberoamericana de Micología, March 2009, Elsevier

    Professor Guillermo Quindós

  118. Actividad de la micafungina contra las biopelículas de Candida

    Article • Revista Iberoamericana de Micología, March 2009, Elsevier

    Professor Guillermo Quindós

  119. Micafungina, una nueva candina para el tratamiento de las micosis invasoras

    Article • Revista Iberoamericana de Micología, March 2009, Elsevier

    Professor Guillermo Quindós

  120. Isolation of Candida dubliniensis in denture stomatitis

    Article • Archives of Oral Biology, February 2009, Elsevier

    Professor Guillermo Quindós

  121. Enteric Fever-Like Syndrome Caused by Raoultella ornithinolytica (Klebsiella ornithinolytica)

    Article • Journal of Clinical Microbiology, January 2009, ASM Journals

    Professor Guillermo Quindós

  122. In VitroAntifungal Activity of Sertaconazole Nitrate Against Recent Isolates of Onychomycosis Causative Agents

    Article • Journal of Chemotherapy, August 2008, Taylor & Francis

    Professor Guillermo Quindós

  123. Anidulafungina en la infección fúngica invasora: perspectivas actuales

    Article • Revista Iberoamericana de Micología, June 2008, Elsevier

    Professor Guillermo Quindós

  124. Actividad antifúngica in vitro de la anidulafungina

    Article • Revista Iberoamericana de Micología, June 2008, Elsevier

    Professor Guillermo Quindós

  125. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis

    Article • International Journal of Antimicrobial Agents, June 2008, Elsevier

    Professor Guillermo Quindós

  126. Latest developments in fungal lung infection in solid organ transplantation (SOT)

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2008, Elsevier

    Professor Guillermo Quindós

  127. En la primera vuelta de la segunda escalera me volví y contemplé: 25 años de Revista Iberoamericana de Micología

    Article • Revista Iberoamericana de Micología, March 2008, Elsevier

    Professor Guillermo Quindós

  128. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre

    Article • International Journal of Antimicrobial Agents, March 2008, Elsevier

    Professor Guillermo Quindós

  129. Evaluación comparativa de ATB Fungus 2 y Sensititre YeastOne en el estudio de la sensibilidad in vitro de Candida a los antifúngicos

    Article • Revista Iberoamericana de Micología, March 2008, Elsevier

    Professor Guillermo Quindós

  130. In Vitro Interactions of Micafungin with Amphotericin B against Clinical Isolates of Candida spp.

    Article • Antimicrobial Agents and Chemotherapy, January 2008, ASM Journals

    Professor Guillermo Quindós

  131. Isolation ofCandida africana, probable atypical strains ofCandida albicans, from a patient with vaginitis

    Article • Medical Mycology, January 2008, Oxford University Press (OUP)

    Professor Guillermo Quindós

  132. Activity of Caspofungin and Voriconazole against Clinical Isolates of Candida and Other Medically Important Yeasts by the CLSI M-44A Disk Diffusion Method with Neo-Sensitabs Tablets

    Article • Chemotherapy, December 2007, Karger Publishers

    Professor Guillermo Quindós

  133. Actividad in vitro de la anfotericina B y la anidulafungina sobre biopelículas de Candida albicans y Candida tropicalis

    Article • Revista Iberoamericana de Micología, December 2007, Elsevier

    Professor Guillermo Quindós

  134. Identificación rápida de Candida dubliniensis mediante la prueba Bichro-Dubli®

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2007, Elsevier

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  135. In vitro activity of micafungin combined with itraconazole against Candida spp.

    Article • International Journal of Antimicrobial Agents, November 2007, Elsevier

    Professor Guillermo Quindós

  136. Presente y futuro de voriconazol en el tratamiento de las micosis invasoras: el inseparable binomio diagnóstico-tratamiento

    Article • Revista Iberoamericana de Micología, September 2007, Elsevier

    Professor Guillermo Quindós

  137. Actividad antifúngica in vitro de voriconazol: Nuevos datos después de los primeros años de experiencia clínica

    Article • Revista Iberoamericana de Micología, September 2007, Elsevier

    Professor Guillermo Quindós

  138. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis

    Article • International Journal of Antimicrobial Agents, August 2007, Elsevier

    Professor Guillermo Quindós

  139. Comparación de un método de amplificación aleatoria del ADN polimorfo (RAPD) y el sistema ATB ID32C para la identificación de aislamientos clínicos de Candida

    Article • Revista Iberoamericana de Micología, June 2007, Elsevier

    Professor Guillermo Quindós

  140. In vitro interaction of micafungin and fluconazole against Candida

    Article • Journal of Antimicrobial Chemotherapy, May 2007, Oxford University Press (OUP)

    Professor Guillermo Quindós

  141. Comparison of Tablet and Disk Diffusion Methods for Fluconazole and VoriconazoleIn VitroActivity Testing Against Clinical Yeast Isolates

    Article • Journal of Chemotherapy, April 2007, Taylor & Francis

    Professor Guillermo Quindós

  142. La valiosa incorporación del nuevo Director ejecutivo, Josep Guarro i Artigas

    Article • Revista Iberoamericana de Micología, March 2007, Elsevier

    Professor Guillermo Quindós

  143. Biofilm development by clinical isolates ofMalassezia pachydermatis

    Article • Medical Mycology, January 2007, Oxford University Press (OUP)

    Professor Guillermo Quindós

  144. Update on invasive fungal infections: the last two years

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2007, Elsevier

    Professor Guillermo Quindós

  145. New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi

    Article • Clinical Microbiology and Infection, December 2006, Elsevier

    Professor Guillermo Quindós

  146. Utilidad de la detección de (1→3)-ß-D-glucano y anticuerpos anti-micelio de Candida albicans para el diagnóstico y seguimiento terapéutico de la candidiasis invasora en pacientes neutropénicos adultos

    Article • Revista Iberoamericana de Micología, December 2006, Elsevier

    Professor Guillermo Quindós

  147. Aislamiento de Issatchenkia occidentalis en el esófago de un paciente con leucemia

    Article • Revista Iberoamericana de Micología, December 2006, Elsevier

    Professor Guillermo Quindós

  148. In Vitro Activities of Voriconazole and Five Licensed Antifungal Agents Against Candida dubliniensis: Comparison of CLSI M27-A2, Sensititre YeastOne, Disk Diffusion, and Etest Methods

    Article • Microbial Drug Resistance, December 2006, Mary Ann Liebert Inc

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  149. Evaluation of the New Chromogenic Medium Candida ID 2 for Isolation and Identification of Candida albicans and Other Medically Important Candida Species

    Article • Journal of Clinical Microbiology, September 2006, ASM Journals

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  150. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast OneTM

    Article • Mycoses, July 2006, Wiley

    Professor Guillermo Quindós

  151. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans

    Article • Diagnostic Microbiology and Infectious Disease, June 2006, Elsevier

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  152. Anticuerpos anti-micelio de Candida albicans en dos pacientes de cuidados intensivos con candidiasis invasora

    Article • Revista Iberoamericana de Micología, March 2006, Elsevier

    Professor Guillermo Quindós

  153. Mecanismos de resistencia a la terapéutica antifúngica

    Article • Medicina Clínica, January 2006, Elsevier

    Professor Guillermo Quindós

  154. Usefulness of Candida ID2 agar for the presumptive identification ofCandida dubliniensis

    Article • Medical Mycology, January 2006, Oxford University Press (OUP)

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  155. Introduction to the special issue of the Revista Iberoamericana de Micología devoted to Fungal Genomes

    Article • Revista Iberoamericana de Micología, December 2005, Elsevier

    Professor Guillermo Quindós

  156. Supplementation of CHROMagar Candida Medium with Pal's Medium for Rapid Identification of Candida dubliniensis

    Article • Journal of Clinical Microbiology, November 2005, ASM Journals

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  157. Oral Candida Isolates Colonizing or Infecting Human Immunodeficiency Virus-Infected and Healthy Persons in Mexico

    Article • Journal of Clinical Microbiology, August 2005, ASM Journals

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  158. Sertaconazole: updated review of a topical antifungal agent

    Article • Expert Review of Anti-infective Therapy, June 2005, Taylor & Francis

    Professor Guillermo Quindós

  159. Actividad antifúngica in vitro de voriconazol contra dermatofitos y aislamientos superficiales de Scopulariopsis brevicaulis

    Article • Revista Iberoamericana de Micología, June 2005, Elsevier

    Professor Guillermo Quindós

  160. Prevalencia, microbiología y patrones de sensibilidad a los antifúngicos de los aislamientos orales de Candida que colonizaban o infectaban a pacientes mexicanos con infección por VIH o sida y a personas sanas

    Article • Revista Iberoamericana de Micología, June 2005, Elsevier

    Professor Guillermo Quindós

  161. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

    Article • Journal of Antimicrobial Chemotherapy, March 2005, Oxford University Press (OUP)

    Professor Guillermo Quindós

  162. Current Developments in Anti-Fungal Agents

    Article • Current Medicinal Chemistry - Anti-Infective Agents, December 2004, Bentham Science Publishers

    Professor Guillermo Quindós

  163. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

    Article • Diagnostic Microbiology and Infectious Disease, November 2004, Elsevier

    Professor Guillermo Quindós, Professor Maria-Dolores Moragues

  164. Antifungal Activity of Amphotericin B and Itraconazole against Filamentous Fungi: Comparison of the Sensititre Yeast OneŴ and NCCLS M38-A Reference Methods

    Article • Journal of Chemotherapy, October 2004, Taylor & Francis

    Professor Guillermo Quindós

  165. Evaluación de una nueva técnica comercializada (Candida albicans IFA IgG) para el diagnóstico de la candidiasis invasiva

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Professor Guillermo Quindós

  166. In vitro Antifungal Activity of Sertaconazole Compared with Nine Other Drugs against 250 Clinical Isolates of Dermatophytes and Scopulariopsis brevicaulis

    Article • Chemotherapy, January 2004, Karger Publishers

    Professor Guillermo Quindós

  167. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

    Article • Journal of Antimicrobial Chemotherapy, December 2003, Oxford University Press (OUP)

    Professor Guillermo Quindós

  168. Performance of BacticardTM Candida compared with the germ tube test for the presumptive identification of Candida albicans

    Article • Mycoses, November 2003, Wiley

    Professor Guillermo Quindós

  169. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species

    Article • Diagnostic Microbiology and Infectious Disease, March 2003, Elsevier

    Professor Guillermo Quindós

  170. Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method

    Article • Journal of Antimicrobial Chemotherapy, November 2002, Oxford University Press (OUP)

    Professor Guillermo Quindós

  171. Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates

    Article • International Journal of Antimicrobial Agents, November 2002, Elsevier

    Professor Guillermo Quindós

  172. Candida dubliniensis, a new fungal pathogen

    Article • Journal of Basic Microbiology, June 2002, Wiley

    Professor Guillermo Quindós, Professor - Specialist in Clinical Microbiology - BSc Medicine Jose Gutierrez-Fernandez

  173. Comparison of in vitro Antifungal Activities of Amphotericin B Lipid Complex with Itraconazole against 708 Clinical Yeast Isolates and Opportunistic Moulds Determined by National Committee for Clinical Laboratory Standards Methods M27-A and M38-P

    Article • Chemotherapy, January 2002, Karger Publishers

    Professor Guillermo Quindós

  174. Comparison of the Sensititre YeastOne Colorimetric Microdilution Panel and the NCCLS Broth Microdilution Method for Antifungal Susceptibility Testing against Candida Species

    Article • Chemotherapy, January 2002, Karger Publishers

    Professor Guillermo Quindós

  175. Serological Differentiation of Experimentally Induced Candida dubliniensis and Candida albicans Infections

    Article • Journal of Clinical Microbiology, August 2001, ASM Journals

    Professor Guillermo Quindós, David C Coleman, Professor Maria-Dolores Moragues

  176. Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns

    Article • Clinical Microbiology and Infection, June 2001, Elsevier

    Professor Guillermo Quindós

  177. S2.5 Nuevas perspectivas en la terapia antifúngica

    Article • Gaceta Médica de Bilbao, January 2001, Elsevier

    Professor Guillermo Quindós

  178. Sertaconazole:In-VitroAntifungal Activity Against Vaginal and Other Superficial Yeast Isolates

    Article • Journal of Chemotherapy, January 2001, Taylor & Francis

    Professor Guillermo Quindós

  179. In Vitro Activity of a New Liposomal Nystatin Formulation Against Opportunistic Fungal Pathogens

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2000, Springer Science + Business Media

    Professor Guillermo Quindós

  180. Effect of salivary secretory IgA on the adhesion of Candida albicans to polystyrene

    Article • Microbiology, September 2000, Society for General Microbiology

    Professor Guillermo Quindós

  181. Influence of Environmental pH on the Reactivity of Candida albicans with Salivary IgA

    Article • Journal of Dental Research, June 2000, SAGE Publications

    Professor Guillermo Quindós

  182. Comparative in vitro Antifungal Activity of Amphotericin B Lipid Complex, Amphotericin B and Fluconazole

    Article • Chemotherapy, January 2000, Karger Publishers

    Professor Guillermo Quindós

  183. In vitro Susceptibility of Candida dubliniensis to Current and New Antifungal Agents

    Article • Chemotherapy, January 2000, Karger Publishers

    Professor Guillermo Quindós

  184. In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

    Article • Journal of Antimicrobial Chemotherapy, November 1999, Oxford University Press (OUP)

    Professor Guillermo Quindós

  185. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole

    Article • Journal of Antimicrobial Chemotherapy, September 1999, Oxford University Press (OUP)

    Professor Guillermo Quindós

  186. A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.

    Article • Journal of Antimicrobial Chemotherapy, April 1999, Oxford University Press (OUP)

    Professor Guillermo Quindós

  187. Comparison of morphotypic and genotypic methods for strain delineation inCandida

    Article • Mycoses, December 1997, Wiley

    Professor Guillermo Quindós

  188. Reactivity of Candida albicans Germ Tubes with Salivary Secretory IgA

    Article • Journal of Dental Research, December 1996, SAGE Publications

    Professor Guillermo Quindós

  189. Utility of albicans ID plate for rapid identification of Candida albicans in clinical samples

    Article • Mycopathologia, October 1996, Springer Science + Business Media

    Professor Guillermo Quindós

  190. Effect of monoclonal antibodies directed against Candida albicans cell wall antigens on the adhesion of the fungus to polystyrene

    Article • Microbiology, August 1996, Society for General Microbiology

    Professor Guillermo Quindós

  191. Cytological changes in oral mucosa in denture stomatitis

    Article • Gerodontology, July 1996, Wiley

    Professor Guillermo Quindós

  192. Candida biotypes in patients with oral leukoplakia and lichen planus

    Article • Mycopathologia, May 1996, Springer Science + Business Media

    Professor Guillermo Quindós

  193. Evaluation of a commercial medium for identification ofCandida species

    Article • European Journal of Clinical Microbiology & Infectious Diseases, February 1996, Springer Science + Business Media

    Professor Guillermo Quindós

  194. A new method of antibiotyping yeasts for subspecies discrimination and distribution in human clinical specimens

    Article • European Journal of Epidemiology, February 1996, Springer Science + Business Media

    Professor Guillermo Quindós

  195. Variability in expression of antigens responsible for serotype specificity in Candida albicans

    Article • Microbiology, July 1995, Society for General Microbiology

    Professor Guillermo Quindós

  196. Biotype Diversity of Candida parapsilosis and Its Relationship to the Clinical Source and Experimental Pathogenicity

    Article • The Journal of Infectious Diseases, April 1995, Oxford University Press (OUP)

    Professor Guillermo Quindós

  197. Use of DNA fingerprinting and biotyping methods to study a Candida albicans outbreak in a neonatal intensive care unit

    Article • The Pediatric Infectious Disease Journal, October 1994, Wolters Kluwer Health

    Professor Guillermo Quindós

  198. Fatal Candida famata Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis Who Was Treated with Fluconazole

    Article • Clinical Infectious Diseases, April 1994, Oxford University Press (OUP)

    Professor Guillermo Quindós

  199. Prevalence of Candida parapsilosis in the Oral Cavities of Infants in Spain

    Article • Clinical Infectious Diseases, March 1994, Oxford University Press (OUP)

    Professor Guillermo Quindós

  200. Multicenter Evaluation of ATB Fungus: A Standardized Micromethod for Yeast Susceptibility Testing

    Article • Chemotherapy, January 1994, Karger Publishers

    Professor Guillermo Quindós

  201. Detection of Anti-CandidaalbcansIgE Antibodies in Vaginal Washes from Patients with Acute Vulvovaginal Candidiasis

    Article • Gynecologic and Obstetric Investigation, January 1994, Karger Publishers

    Professor Guillermo Quindós

  202. Fatal Disseminated Infection by Scedosporium inflatum after Bone Marrow Transplantation

    Article • Scandinavian Journal of Infectious Diseases, January 1993, Taylor & Francis

    Professor Guillermo Quindós

  203. Identification of antigens reacting with anti-Candida albicans germ tube antibodies

    Article • European Journal of Epidemiology, May 1992, Springer Science + Business Media

    Professor Guillermo Quindós

  204. Vulvovaginal candidiasis refractory to treatment with fluconazole

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, March 1992, Elsevier

    Professor Guillermo Quindós

  205. Candidal infection of bone: Assessment of serologic tests in diagnosis and management

    Article • Diagnostic Microbiology and Infectious Disease, July 1990, Elsevier

    Professor Guillermo Quindós

  206. In vitro susceptibility ofAeromonas caviae, Aeromonas hydrophila andAeromonas sobria to fifteen antibacterial agents

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 1990, Springer Science + Business Media

    Professor Guillermo Quindós

  207. Value of detection of antibodies toCandida albicans germ tube in the diagnosis of systemic candidosis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 1990, Springer Science + Business Media

    Professor Guillermo Quindós

  208. Determination of monosaccharides by high-performance liquid chromatography in systemic candidosis

    Article • Journal of Chromatography B Biomedical Sciences and Applications, January 1990, Elsevier

    Professor Guillermo Quindós

  209. Vulvovaginal Candidiasis: pathogenesis and diagnosis

    Article • Gynecologic and Obstetric Investigation, January 1990, Karger Publishers

    Professor Guillermo Quindós

  210. Antibodies against Trichosporon beigelii in vaginal washings from asymptomatic women

    Article • Journal of Medical Microbiology, March 1989, Society for General Microbiology

    Professor Guillermo Quindós

  211. Isolation of dysgonic strains ofMicrosporum canisin Bilbao (Spain)

    Article • Medical Mycology, January 1989, Oxford University Press (OUP)

    Professor Guillermo Quindós

  212. Detection of antibodies toCandida albicans germ tube in the diagnosis of systemic candidiasis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 1987, Springer Science + Business Media

    Professor Guillermo Quindós

  213. Cellular and humoral immune responses to Candida albicans in subcutaneously infected mice

    Article • Mycopathologia, October 1985, Springer Science + Business Media

    Professor Guillermo Quindós

  214. Typing Fungal Isolates: Molecular Methods and Computerized Analysis

    Article • Springer Science + Business Media

    Professor Guillermo Quindós

  215. Trichosporon, Magnusiomyces, and Geotrichum

    Article • Taylor & Francis

    Professor Guillermo Quindós